Newsletter Current page: 2

Guillaume Balz joined the SHS team as Investment Manager in January 2023. After obtaining his Bachelor’s degree in Business and Economics in Dortmund and Athens, he completed his Master’s degree in Finance and Strategic Management in Copenhagen. He then decided to join Simon-Kucher, where he advised companies on marketing, sales, pricing and go-to-market. From the […]

Salvia BioElectronics, a pioneering Dutch company specialising in the treatment and cure of severe migraines, announced the successful first implantation of its paper-thin neuromodulation solution. Migraine is the most common cause of disability in people under 50 and affects one in seven people, mainly women. More than five percent of migraine patients suffer from chronic […]

French company PathoQuest has entered into a strategic partnership with Oxford Nanopore Technologies to bring to market the first sequencing-based quality control test for the genetic characterisation of biopharmaceuticals. Most biologics are produced using genetically modified cell lines. For many cell therapies, the product itself is a genetically modified cell line. Throughout the development of […]

You joined SHS this February to support the team in its market activities, especially in the areas of business development, communication and deal-sourcing. What was your motivation to work for SHS? With over 35 years of professional experience in M&A consulting and private equity, I have built a very extensive network of contacts and enjoy […]

Ruth Ch. Gessner has been SHS Senior Advisor since the beginning of 2023. She specializes in the profitable realignment of companies in the medical technology sector. Over the past 20 years, she has successfully led business units as Vice President at Danaher / Dental as well as at other leading listed corporations. She was also […]

Siegfried Schabel has held the dual role of CEO and CFO for Tyromotion since October 2022. In his last role, he was CEO of a global group with business areas in medical devices (in-vitro diagnostics), cutting machines and products for the welding, soldering and thermal coating markets. Mr. Schabel on Tyromotion GmbH: “It is a […]

Develco Pharma AG has elected a new chairman of its board of directors. The previous chairman, Markus Zimmer, has handed over his office to the newly elected chairman, Steffen Wagner. Mr. Wagner has broad general management experience in international life science businesses. He is a medical doctor by training, has previously held senior roles with […]

TRI Dental Implants Int. AG was able to win Patterson Dental as an authorized distribution partner for its TRI® matrix® implant system, which thus becomes the first dental implant without abutment in the United States. Using digital fabrication technologies such as 3D printers and CAD/CAM milling machines, TRI-Matrix implant technology enables a 3-5-fold increase in […]

Our SHS portfolio company Selfapy has closed a 7 million euro funding round. MEDICE Arzneimittel Pütter GmbH & Co KG has come on board as a new investor. In addition, all existing investors have participated in the new financing round. The aim of the investment is to establish further digital health applications for mental illnesses […]

After the Scandinavian start-up Dr.Dropin has already opened 25 clinic locations in Norway, the digital-analogue health provider is now conquering other countries. In Sweden, the company already has two branches. Now Dr.Dropin also wants to open its first clinic in Switzerland. Click here for the full article: LINK

SIS Medical AG (Swiss Interventional Systems), a leading global developer, manufacturer and distributor of high-quality, high-performance interventional cardiology products, announces the US launch of its flagship product, the OPN NC® PTCA Dilatation Catheter with TWIN-Wall Technology. The product expands treatment options with high performance and safety, providing success rates where other balloons fail. The OPN […]

1. You have been part of the SHS team since September 2022. Before that, you were an associate at a renowned investment bank in Frankfurt. What was your field of activity there? I was employed as an analyst for 2.5 years before I was promoted to associate shortly before leaving. I mainly worked on M&A […]